Literature DB >> 10694947

Inactivation patterns of the p16 (INK4a) gene in oral squamous cell carcinoma cell lines.

D Akanuma1, N Uzawa, M A Yoshida, A Negishi, T Amagasa, T Ikeuchi.   

Abstract

To determine whether inactivation of the p16 gene mapped to the chromosome 9p21 region is associated with the development of oral squamous cell carcinoma (SCC), we investigated the mutational states of two forms of alternative transcripts (alpha and beta) from the p16 gene in 14 oral SCC cell lines by means of RT-PCR, PCR, direct sequencing and methylation analyses. Alterations of the alpha transcript were detected in all of the cell lines examined: homozygous deletions in three lines; subtle mutations in exons 1 alpha or 2 in four lines; skipping of exon 2 in two lines; hypermethylation of the 5' CpG island of the p16 gene in four lines; and an unknown mechanism in one line. On the other hand, abnormalities of the beta transcript were observed in seven of the 14 cell lines. Nonetheless, the mutations that essentially affect the function of the encoded protein were found only in five cell lines, including three lines with homozygous deletion. There was no cell line having only beta transcript alterations. Thus, alteration of the alpha transcript of the p16 gene was a highly frequent event in oral SCC. Since this type of alteration resulted in gene inactivation through multiple pathways, it may play a major role in the process of oral SCC development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10694947     DOI: 10.1016/s1368-8375(99)00020-2

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.

Authors:  Jens P Klussmann; Elif Gültekin; Soenke J Weissenborn; Ulrike Wieland; Volker Dries; Hans P Dienes; Hans E Eckel; Herbert J Pfister; Pawel G Fuchs
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

2.  Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma.

Authors:  Phuong Xuan Tran; Jun Inoue; Hiroyuki Harada; Johji Inazawa
Journal:  Mol Ther Oncolytics       Date:  2022-03-08       Impact factor: 6.311

3.  Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients.

Authors:  Katarzyna Kiwerska; Małgorzata Rydzanicz; Andrzej Kram; Martyna Pastok; Agata Antkowiak; Wenancjusz Domagała; Krzysztof Szyfter
Journal:  Mol Biol Rep       Date:  2009-08-19       Impact factor: 2.316

4.  Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC).

Authors:  D J Smiraglia; L T Smith; J C Lang; L J Rush; Z Dai; D E Schuller; C Plass
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

5.  Methylation-mediated molecular dysregulation in clinical oral malignancy.

Authors:  Rebecca Towle; Cathie Garnis
Journal:  J Oncol       Date:  2012-05-07       Impact factor: 4.375

6.  Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma.

Authors:  S Gao; J Worm; P Guldberg; H Eiberg; A Krogdahl; J A Sørensen; C-J Liu; J Reibel; E Dabelsteen
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.